I view this as a mild positive - there must be a perception by the MD that it is an active drug to seek this out. I would think if the pt met criteria for the randomized trial currently enrolling they would have triaged her to the trial. I would think if FGEN wants to expand the randomized trial to this site they would have interest
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.